{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:48:30Z","timestamp":1791136110779,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T00:00:00Z","timestamp":1093305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>In a prospective study of 109 subjects, an enzyme\u2010linked immunosorbent assay (ELISA) was used to measure platelet\u2010rich plasma (PRP) serotonin levels in patients with polycythaemia vera (PV; <jats:italic>n<\/jats:italic>\u2003=\u200327), essential thrombocythaemia (ET; <jats:italic>n<\/jats:italic>\u2003=\u200314), myelofibrosis with myeloid metaplasia (MMM; <jats:italic>n<\/jats:italic>\u2003=\u200330), secondary or spurious polycythaemia (SP; <jats:italic>n<\/jats:italic>\u2003=\u200322) and controls (<jats:italic>n<\/jats:italic>\u2003=\u200316). Nine study subjects who were taking a selective serotonin reuptake inhibitor (SSRI) all displayed a markedly decreased PRP serotonin level (median, 24\u00b72\u2003ng\/10<jats:sup>9<\/jats:sup>\u2003platelets; range, 0\u201349\u00b73) and were therefore excluded from further analysis. Among the remaining 100 subjects, the median and range of PRP serotonin levels, in ng\/10<jats:sup>9<\/jats:sup>\u2003platelets, was significantly lower in MMM (89\u00b75; 0\u2013278\u00b73), PV (204\u00b78; 0\u2013496\u00b70) and ET (385\u00b73; 136\u00b78\u20131025\u00b77) compared with both SP (608\u00b78; 369\u00b70\u20131780\u00b71) and controls (567\u00b72; 359\u00b79\u20131071\u00b71). Neutrophil polycythaemia rubra vera\u20101 (PRV\u20101) expression was concurrently assayed by real\u2010time polymerase chain reaction in 69 patients (23 PV, 17 SP, 12 ET, seven MMM, 10 controls). PRP serotonin measurement performed as well as the PRV\u20101 assay in distinguishing PV from SP (93% vs. 86% test accuracy). The current study suggests that PRP serotonin concentration might be considered as one of the several biological markers that complement each other for the diagnosis of PV.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05149.x","type":"journal-article","created":{"date-parts":[[2004,9,22]],"date-time":"2004-09-22T15:40:17Z","timestamp":1095867617000},"page":"34-39","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Platelet\u2010rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV\u20101 assay"],"prefix":"10.1111","volume":"127","author":[{"given":"Cody A.","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra L.","family":"Lasho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayalew","family":"Tefferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,24]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1974.tb00262.x"},{"key":"e_1_2_15_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90568-6"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/95.1.82"},{"key":"e_1_2_15_5_1","first-page":"2683","article-title":"Abnormalities of platelet function in patients with polycythemia vera","volume":"33","author":"Berger S.","year":"1973","journal-title":"Cancer Research"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1981.tb01391.x"},{"key":"e_1_2_15_7_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0038-1661099","article-title":"Abnormal platelet serotonin uptake and binding sites in myeloproliferative disorders","volume":"51","author":"Caranobe C.","year":"1984","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_15_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(82)90307-3"},{"key":"e_1_2_15_9_1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/clinchem\/37.7.1178","article-title":"Rapid and specific enzyme immunoassay of serotonin","volume":"37","author":"Chauveau J.","year":"1991","journal-title":"Clinical Chemistry"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1985.tb02247.x"},{"key":"e_1_2_15_11_1","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1182\/blood.V91.9.3357","article-title":"Highly sensitive fluorescence in situ hybridization method to detect double BCR\/ABL fusion and monitor response to therapy in chronic myeloid leukemia","volume":"91","author":"Dewald G.W.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.thj.6200123"},{"key":"e_1_2_15_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000206503"},{"key":"e_1_2_15_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(87)90449-9"},{"key":"e_1_2_15_15_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2000.110456"},{"key":"e_1_2_15_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199210000-00026"},{"key":"e_1_2_15_17_1","volume-title":"WHO Classification of Tumors: Tumors of the Hematopoietic and Lymphoid Tissues","author":"Jaffe E.S.","year":"2001"},{"key":"e_1_2_15_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(00)00129-3"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(93)80337-4"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0919"},{"key":"e_1_2_15_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00361.x"},{"key":"e_1_2_15_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1991.tb00246.x"},{"key":"e_1_2_15_23_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2001.03302.x"},{"key":"e_1_2_15_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03386.x"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802263380903"},{"key":"e_1_2_15_26_1","first-page":"9","article-title":"Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia","volume":"36","author":"Murphy S.","year":"1999","journal-title":"Seminars in Hematology"},{"key":"e_1_2_15_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.138.8.1251"},{"key":"e_1_2_15_28_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0038-1657135","article-title":"Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders","volume":"47","author":"Pareti F.I.","year":"1982","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_15_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0037-1963(01)90136-2"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/91.6.647"},{"key":"e_1_2_15_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V64.1.1.1"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.4.1342"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199901)60:1<12::AID-AJH3>3.0.CO;2-P"},{"key":"e_1_2_15_34_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood.V30.1.54.54","article-title":"Histochemical demonstration of 5\u2010hydroxytryptamine in platelets and megakaryocytes","volume":"30","author":"Tanaka C.","year":"1967","journal-title":"Blood"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.2.174"},{"key":"e_1_2_15_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.2.771"},{"key":"e_1_2_15_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-10-3505"},{"key":"e_1_2_15_38_1","first-page":"368","article-title":"The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias","volume":"86","author":"Thiele J.","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.52.1.191"},{"key":"e_1_2_15_40_1","first-page":"432","article-title":"Abnormal platelet function in myeloproliferative disorders","volume":"105","author":"Waddell C.C.","year":"1981","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"e_1_2_15_41_1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1055\/s-0038-1651925","article-title":"The role of platelets in the pathogenesis of thrombosis and hemorrhage in patients with thrombocytosis","volume":"38","author":"Walsh P.N.","year":"1977","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_15_42_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0038-1661198","article-title":"Abnormalities of epinephrine\u2010induced platelet aggregation and adenine nucleotides in myeloproliferative disorders","volume":"52","author":"Yamamoto K.","year":"1984","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_15_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1991.tb01855.x"},{"key":"e_1_2_15_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/107602969700300215"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05149.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05149.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05149.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:43:50Z","timestamp":1697417030000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05149.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,24]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05149.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05149.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,24]]},"assertion":[{"value":"2004-08-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}